Traditional Chinese medicine in the treatment of systemic lupus erythematosus: a prospective cohort study
Not Applicable
Recruiting
- Conditions
- Systemic lupus erythematosus
- Registration Number
- ITMCTR2000003114
- Lead Sponsor
- The Second Affiliated Hospital of Zhejiang Chinese Medicine University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Conforms to the SLE classification standard formulated by SLICC in 2009;
2. Aged between 14 and 65;
3. The patient was informed and agreed to participate in the study.
Exclusion Criteria
1. Patients with end-stage renal disease, grade IV heart failure (NYHA classification), liver failure, sepsis, and malignant tumors;
2. Patients with severe or poorly controlled hypertension (SBP >= 160mmHg or DBP>= 90mmHg) or diabetes (HbA1c> 8%);
3. Schizophrenia or other mental illness patients who cannot fully recognize their behavior;
4. Pregnant or lactating women.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SLEDAI score;
- Secondary Outcome Measures
Name Time Method Incidence of infection;Disease recurrence rate;TCM syndrome score;LupusHoL scale;Glucocorticoid dosage;Systemic lupus erythematosus cumulative organ damage index;